A Single-center, Open-label, Randomized, Double-crossover, Propofol-controlled, Two-stage Study Evaluating the Safety and Pharmacokinetics/Pharmacodynamics of IV Maintenance Dose After An Initial Dose and IV Single Loade Dose Plus Maintenance Dose of HSK3486 Emulsion fo Injection in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 21 Aug 2019
Price : $35 *
At a glance
- Drugs HSK 3486 (Primary) ; Propofol
- Indications Anaesthesia; Sedation
- Focus Adverse reactions
- Sponsors Sichuan Haisco Pharmaceutical
- 19 Aug 2019 Planned End Date changed from 1 Apr 2019 to 1 Sep 2019.
- 19 Aug 2019 Planned primary completion date changed from 1 Jun 2019 to 1 Aug 2019.
- 24 May 2019 Planned primary completion date changed from 28 Feb 2019 to 1 Jun 2019.